173 related articles for article (PubMed ID: 27721405)
21. Expression and prognostic significance of ELL-associated factor 2 in human prostate cancer.
Zang Y; Dong Y; Yang D; Xue B; Li F; Gu P; Zhao H; Wang S; Zhou S; Ying R; Wang Z; Shan Y
Int Urol Nephrol; 2016 May; 48(5):695-700. PubMed ID: 26895851
[TBL] [Abstract][Full Text] [Related]
22. Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells.
Qiao Z; Wang D; Hahn J; Ai J; Wang Z
Prostate; 2014 Feb; 74(2):113-20. PubMed ID: 24272884
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53.
Su F; Pascal LE; Xiao W; Wang Z
Oncogene; 2010 Jan; 29(3):421-31. PubMed ID: 19826414
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
[TBL] [Abstract][Full Text] [Related]
25. SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells.
Roth M; Wang Z; Chen WY
Oncotarget; 2016 Aug; 7(31):50195-50214. PubMed ID: 27384990
[TBL] [Abstract][Full Text] [Related]
26. Expression of Ku70 predicts results of radiotherapy in prostate cancer.
Hasegawa T; Someya M; Hori M; Matsumoto Y; Nakata K; Nojima M; Kitagawa M; Tsuchiya T; Masumori N; Hasegawa T; Sakata KI
Strahlenther Onkol; 2017 Jan; 193(1):29-37. PubMed ID: 27465041
[TBL] [Abstract][Full Text] [Related]
27. Suppressing Ku70/Ku80 expression elevates homology-directed repair efficiency in primary fibroblasts.
Li G; Liu D; Zhang X; Quan R; Zhong C; Mo J; Huang Y; Wang H; Ruan X; Xu Z; Zheng E; Gu T; Hong L; Li Z; Wu Z; Yang H
Int J Biochem Cell Biol; 2018 Jun; 99():154-160. PubMed ID: 29655920
[TBL] [Abstract][Full Text] [Related]
28. Calcium influx-mediated translocation of m-calpain induces Ku80 cleavage and enhances the Ku80-related DNA repair pathway.
Baek KH; Yu HV; Kim E; Na Y; Kwon Y
Oncotarget; 2016 May; 7(21):30831-44. PubMed ID: 27121057
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
30. Negative feedback regulation of Wnt4 signaling by EAF1 and EAF2/U19.
Wan X; Ji W; Mei X; Zhou J; Liu JX; Fang C; Xiao W
PLoS One; 2010 Feb; 5(2):e9118. PubMed ID: 20161747
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.
Alshareeda AT; Negm OH; Albarakati N; Green AR; Nolan C; Sultana R; Madhusudan S; Benhasouna A; Tighe P; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2013 Jun; 139(2):301-10. PubMed ID: 23624778
[TBL] [Abstract][Full Text] [Related]
32. DNA-PKcs expression predicts response to radiotherapy in prostate cancer.
Bouchaert P; Guerif S; Debiais C; Irani J; Fromont G
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1179-85. PubMed ID: 22494583
[TBL] [Abstract][Full Text] [Related]
33. Gene Expression Profiling Reveals Regulation of ERK Phosphorylation by Androgen-Induced Tumor Suppressor U19/EAF2 in the Mouse Prostate.
Su F; Correa BR; Luo J; Vencio RZ; Pascal LE; Wang Z
Cancer Microenviron; 2013 Dec; 6(3):247-61. PubMed ID: 23440596
[TBL] [Abstract][Full Text] [Related]
34. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells.
Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C
Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526
[TBL] [Abstract][Full Text] [Related]
35. RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells.
Mukhopadhyay UK; Senderowicz AM; Ferbeyre G
Cancer Res; 2005 Apr; 65(7):2872-81. PubMed ID: 15805289
[TBL] [Abstract][Full Text] [Related]
36. Cleavage of Ku80 by caspase-2 promotes non-homologous end joining-mediated DNA repair.
Yan Q; Zhu H; Lan L; Yi J; Yang J
DNA Repair (Amst); 2017 Dec; 60():18-28. PubMed ID: 29065392
[TBL] [Abstract][Full Text] [Related]
37. BCL2-overexpressing prostate cancer cells rely on PARP1-dependent end-joining and are sensitive to combined PARP inhibitor and radiation therapy.
Oing C; Tennstedt P; Simon R; Volquardsen J; Borgmann K; Bokemeyer C; Petersen C; Dikomey E; Rothkamm K; Mansour WY
Cancer Lett; 2018 Jun; 423():60-70. PubMed ID: 29526801
[TBL] [Abstract][Full Text] [Related]
38. FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity.
Jiang F; Ai J; Xiao W; Wang Z
Cancer Lett; 2007 Aug; 253(2):265-72. PubMed ID: 17395368
[TBL] [Abstract][Full Text] [Related]
39. The DNA damage repair protein Ku70 regulates tumor cell and hepatic carcinogenesis by interacting with FOXO4.
Zhang T; Zhang X; Shi W; Xu J; Fan H; Zhang S; Ni R
Pathol Res Pract; 2016 Mar; 212(3):153-61. PubMed ID: 26797321
[TBL] [Abstract][Full Text] [Related]
40. A novel small molecule inhibitor of the DNA repair protein Ku70/80.
Weterings E; Gallegos AC; Dominick LN; Cooke LS; Bartels TN; Vagner J; Matsunaga TO; Mahadevan D
DNA Repair (Amst); 2016 Jul; 43():98-106. PubMed ID: 27130816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]